These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38618967)

  • 1. The RNA-binding protein RBMS3 inhibits the progression of colon cancer by regulating the stability of LIMS1 mRNA.
    Li Y; Wang S; Li G; Gao C; Cui Z; Cong M; Hu J; Zhang M; Jin X; Sun H; Kong D
    Cancer Med; 2024 Apr; 13(7):e7129. PubMed ID: 38618967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down regulation of RNA binding motif, single-stranded interacting protein 3, along with up regulation of nuclear HIF1A correlates with poor prognosis in patients with gastric cancer.
    Wu Y; Yun D; Zhao Y; Wang Y; Sun R; Yan Q; Zhang S; Lu M; Zhang Z; Lu D; Li Y
    Oncotarget; 2017 Jan; 8(1):1262-1277. PubMed ID: 27902480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RBMS3, a downstream target of AMPK, Exerts Inhibitory Effects on Invasion and Metastasis of Lung Cancer.
    Lv SL; Zhou X; Li YJ; Luo LY; Huang DQ
    J Cancer; 2023; 14(15):2784-2797. PubMed ID: 37781074
    [No Abstract]   [Full Text] [Related]  

  • 4. The RNA binding protein RBMS3 inhibits the metastasis of breast cancer by regulating Twist1 expression.
    Zhu L; Xi PW; Li XX; Sun X; Zhou WB; Xia TS; Shi L; Hu Y; Ding Q; Wei JF
    J Exp Clin Cancer Res; 2019 Feb; 38(1):105. PubMed ID: 30819235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA binding protein RBMS3 is a common EMT effector that modulates triple-negative breast cancer progression via stabilizing PRRX1 mRNA.
    Block CJ; Mitchell AV; Wu L; Glassbrook J; Craig D; Chen W; Dyson G; DeGracia D; Polin L; Ratnam M; Gibson H; Wu G
    Oncogene; 2021 Nov; 40(46):6430-6442. PubMed ID: 34608266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RBMS3 at 3p24 inhibits nasopharyngeal carcinoma development via inhibiting cell proliferation, angiogenesis, and inducing apoptosis.
    Chen J; Kwong DL; Zhu CL; Chen LL; Dong SS; Zhang LY; Tian J; Qi CB; Cao TT; Wong AM; Kong KL; Li Y; Liu M; Fu L; Guan XY
    PLoS One; 2012; 7(9):e44636. PubMed ID: 22957092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA MEG3 regulates breast cancer proliferation and apoptosis through miR-141-3p/RBMS3 axis.
    Dong S; Ma M; Li M; Guo Y; Zuo X; Gu X; Zhang M; Shi Y
    Genomics; 2021 Jul; 113(4):1689-1704. PubMed ID: 33845141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of RBMS3 in Breast Cancer Progression.
    Górnicki T; Lambrinow J; Mrozowska M; Romanowicz H; Smolarz B; Piotrowska A; Gomułkiewicz A; Podhorska-Okołów M; Dzięgiel P; Grzegrzółka J
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of RBMS3 predicts a favorable prognosis in human gallbladder carcinoma.
    Wu Y; Meng D; You Y; Sun R; Yan Q; Bao J; Sun Y; Yun D; Li Y; Sun D
    Oncol Rep; 2020 Jul; 44(1):55-68. PubMed ID: 32627033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RBMS3 Inhibits the Proliferation and Metastasis of Breast Cancer Cells.
    Yang Y; Quan L; Ling Y
    Oncol Res; 2018 Jan; 26(1):9-15. PubMed ID: 28409548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum exosomal miR-3662 down-regulates the expression of RBMS3 to promote malignant progression and gemcitabine resistance of breast cancer cells.
    Li X; Chu X; Wang H; Xiang L; Yue X
    Chem Biol Drug Des; 2024 Mar; 103(3):e14488. PubMed ID: 38472166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Suppressor Effect of RBMS3 in Breast Cancer.
    Wang C; Wu Y; Liu Y; Pan F; Zeng H; Li X; Yu L
    Technol Cancer Res Treat; 2021; 20():15330338211004921. PubMed ID: 33910421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA-binding protein RBMS3 is expressed in activated hepatic stellate cells and liver fibrosis and increases expression of transcription factor Prx1.
    Fritz D; Stefanovic B
    J Mol Biol; 2007 Aug; 371(3):585-95. PubMed ID: 17586524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning of a human gene closely related to the genes coding for the c-myc single-strand binding proteins.
    Penkov D; Ni R; Else C; Piñol-Roma S; Ramirez F; Tanaka S
    Gene; 2000 Feb; 243(1-2):27-36. PubMed ID: 10675610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer.
    Yang Z; Wang T; Wu D; Min Z; Tan J; Yu B
    J Exp Clin Cancer Res; 2020 Sep; 39(1):203. PubMed ID: 32993738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive bioinformatics analysis confirms RBMS3 as the central candidate biological target for ovarian cancer.
    Wang M; Fu X; Wang W; Zhang Y; Jiang Z; Gu Y; Chu M; Shao Y; Li S
    Med Eng Phys; 2022 Dec; 110():103883. PubMed ID: 36075788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of RBMS3 suppresses PD-L1 and enhances antitumor immune activities and therapeutic effects of auranofin against triple-negative breast cancer.
    Zhou Y; Liang Z; Xia Y; Li S; Liang J; Hu Z; Tang C; Zhao Q; Gong Q; Ouyang Y
    Chem Biol Interact; 2023 Jan; 369():110260. PubMed ID: 36414028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LIMS1 Promotes Pancreatic Cancer Cell Survival under Oxygen-Glucose Deprivation Conditions by Enhancing HIF1A Protein Translation.
    Huang C; Li Y; Li Z; Xu Y; Li N; Ge Y; Dong J; Chang A; Zhao T; Wang X; Wang H; Yang S; Xie K; Hao J; Ren H
    Clin Cancer Res; 2019 Jul; 25(13):4091-4103. PubMed ID: 30679163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-155 promotes the proliferation and invasion abilities of colon cancer cells by targeting quaking.
    He B; Gao SQ; Huang LD; Huang YH; Zhang QY; Zhou MT; Shi HQ; Song QT; Shan YF
    Mol Med Rep; 2015 Mar; 11(3):2355-9. PubMed ID: 25420938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA RBMS3-AS3 acts as a microRNA-4534 sponge to inhibit the progression of prostate cancer by upregulating VASH1.
    Jiang Z; Zhang Y; Chen X; Wu P; Chen D
    Gene Ther; 2020 Apr; 27(3-4):143-156. PubMed ID: 31712637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.